Covaxin Bharat Biotech：iNCOVACC
iNCOVACC
iNCOVACC-Anoveladenovirusvectored,intranasalvaccineforCOVID-19.COVAXIN,IndiafirstindigenousCOVIDvaccineisdevelopedbythecoronavaccine ...。其他文章還包含有：「Covaxin」、「COVAXINFactsheet」、「CovaxinPIforwebsite」、「COVAXIN®–India'sFirstIndigenousCOVID」、「covaxin」、「factsheetforvaccinerecipients&caregivers」、「SUMMARYOFPRODUCTCHARACTERISTICS(SmPC)」、「TheBharatBiotechBBV152COVAXINv...
查看更多 離開網站
Covaxin
https://en.wikipedia.org
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council ...
COVAXIN Factsheet
https://www.bharatbiotech.com
This Fact Sheet contains information to help you understand the risks and benefits of the Bharat Biotech COVID-19 Vaccine (COVAXIN®). REPORTING OF SIDE EFFECTS.
Covaxin PI for website
https://www.bharatbiotech.com
COVAXINR should be administered as two doses on Day 0 and Day 28. Method of administration: Intramuscular injection (IM). It is recommended that individuals ...
COVAXIN ® – India ' s First Indigenous COVID
https://www.bharatbiotech.com
COVAXIN , India's first indigenous COVID vaccine is developed by the corona vaccine manufacturer Bharat Biotech. It is an inactivated COVID-19 vaccine and ...
covaxin
https://www.bharatbiotech.com
The Bharat Biotech COVID-19 Vaccine (COVAXIN®) is a vaccine with approval for emergency use that may prevent COVID-19. The Central Licensing Authority has ...
fact sheet for vaccine recipients & caregivers
https://www.bharatbiotech.com
WHAT ARE THE BENEFITS OF COVAXIN® ? In the Phase 3 clinical trial, COVAXIN® has been shown to generate immunity following 2 doses given. 4 weeks apart.
SUMMARY OF PRODUCT CHARACTERISTICS (SmPC)
https://www.bharatbiotech.com
COVAXIN® is indicated for active immunization against SARS-CoV-2 Virus infection for age. ≥18years. The vaccine is permitted for restricted use in emergency ...
The Bharat Biotech BBV152 COVAXIN vaccine against ...
https://www.who.int
The vaccine is safe and effective for all individuals aged 18 and above. In line with the WHO Prioritization Roadmap and the WHO Values ...
科瓦克辛
https://zh.wikipedia.org
^ Kumar, N. Ravi. Bharat Biotech says COVID-19 vaccine Covaxin shows 81% efficacy in Phase 3 clinical trials. The Hindu. 2021-03-03 [2021-04-02]. （原始内容存档 ...